
TTK Healthcare Ltd. Reports 6% Revenue Growth in FY 2024-25, EPS at Rs.57.79
TTK Healthcare Ltd. has reported a 6% growth in revenue from operations for the financial year 2024-25, amounting to Rs.801.49 crores. The pre-tax profit stood at Rs.108.33 crores, including one-time income of Rs.19.77 crores and write-off of inventories of Rs.5.86 crores. Earnings per share (EPS) were reported at Rs.57.79. The company carries a free cash balance of around Rs.900 crores. The Consumer Products Business reported a static performance, with Woodward’s Gripe Water facing a significant drop in volumes. However, EVA and Skore reported growth of 5% and 12% respectively. Good Home sustained its positive momentum with 15% growth. Love Depot / MsChief, the Company’s digital-first platform for Pleasure Products, reported a healthy growth. Animal Welfare Business reported a revenue growth of around 9%. The Medical Devices Business: Heart Valve Division reported a value growth of only 3%.
Key Highlights
- TTK Healthcare reports 6% growth in revenue from operations for FY 2024-25
- Pre-tax profit stands at Rs.108.33 crores
- EPS reported at Rs.57.79
- Consumer Products Business reports static performance
- Medical Devices Business: Heart Valve Division reports 3% value growth